AWM Capital LLC reduced its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,454 shares of the company’s stock after selling 85 shares during the period. AWM Capital LLC’s holdings in […]
Warther Private Wealth LLC cut its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 75.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,036 shares of the company’s stock after selling 15,592 shares during the quarter. AbbVie accounts for about […]
Loudon Investment Management LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,693 shares of the company’s stock after selling 758 shares during the quarter. AbbVie makes up approximately 2.4% […]
Bey Douglas LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,629 shares of the company’s stock, valued at approximately $252,000. A number of other institutional investors have also modified their […]
Cary Street Partners Investment Advisory LLC raised its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 120,384 shares of the company’s stock after acquiring an additional 1,930 shares during the quarter. […]
Econ Financial Services Corp reduced its stake in Verizon Communications Inc. (NYSE:VZ – Free Report) by 12.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 56,307 shares of the cell phone carrier’s stock after selling 7,654 shares during the period. Verizon Communications accounts […]
Bard Financial Services Inc. lifted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,105 shares of the company’s stock after purchasing an additional 1,440 shares during the period. AbbVie makes up […]
Edgemoor Investment Advisors Inc. lowered its position in Pfizer Inc. (NYSE:PFE – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,859 shares of the biopharmaceutical company’s stock after selling 822 shares during the quarter. Edgemoor Investment Advisors Inc.’s […]
Montrusco Bolton Investments Inc. cut its stake in shares of Walmart Inc. (NYSE:WMT – Free Report) by 22.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,692,382 shares of the retailer’s stock after selling 478,099 shares during the period. Walmart comprises […]
Sweetgreen, Inc. (NYSE:SG – Get Free Report) CEO Jonathan Neman sold 200,000 shares of Sweetgreen stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $31.30, for a total transaction of $6,260,000.00. Following the completion of the transaction, the chief executive officer now owns 2,100,000 shares of the […]
Berger Financial Group Inc decreased its holdings in The Home Depot, Inc. (NYSE:HD – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,525 shares of the home improvement retailer’s stock after selling 133 shares during the quarter. […]
Investment Management Associates Inc. ADV decreased its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 25.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,869 shares of the biopharmaceutical company’s stock after selling 6,789 shares during the quarter. […]